Biocartis Group N.V.
BIOGF · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $37 | $228 | $208 | $225 |
| - Cash | $25 | $52 | $122 | $178 |
| + Debt | $122 | $154 | $151 | $167 |
| Enterprise Value | $135 | $330 | $237 | $214 |
| Revenue | $57 | $48 | $43 | $37 |
| % Growth | 19.1% | 11.9% | 15.2% | – |
| Gross Profit | $28 | $14 | $17 | $16 |
| % Margin | 48.2% | 29.7% | 39.1% | 43% |
| EBITDA | -$44 | -$53 | -$43 | -$47 |
| % Margin | -76.5% | -108.9% | -100.2% | -126.5% |
| Net Income | -$65 | -$71 | -$63 | -$64 |
| % Margin | -113.7% | -148.1% | -145.9% | -171.1% |
| EPS Diluted | -1.08 | -1.24 | -1.11 | -1.14 |
| % Growth | 12.9% | -11.7% | 2.6% | – |
| Operating Cash Flow | -$45 | -$66 | -$39 | -$54 |
| Capital Expenditures | -$2 | -$4 | -$3 | -$3 |
| Free Cash Flow | -$47 | -$69 | -$42 | -$57 |